StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lipella Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2025 was -1367.4%. For fiscal 2024 it was -935.2%, against -1027.3% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-935.2%+92.1
FY2023Dec 31, 2023-1027.3%+383.3
FY2022Dec 31, 2022-1410.6%−691.3
FY2021Dec 31, 2021-719.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2025Jun 30, 2025-1530.6%−843.0
Q1 FY2025Mar 31, 2025-1009.8%−192.8
Q4 FY2024Dec 31, 2024-830.1%−260.1
Q3 FY2024Sep 30, 2024-1797.3%−525.2
Q2 FY2024Jun 30, 2024-687.6%+754.8
Q1 FY2024Mar 31, 2024-817.0%+87.6
Q4 FY2023Dec 31, 2023-570.1%−329.1
Q3 FY2023Sep 30, 2023-1272.0%+954.1
Q2 FY2023Jun 30, 2023-1442.4%–
Q1 FY2023Mar 31, 2023-904.6%–
Q4 FY2022Dec 31, 2022-241.0%–
Q1 FY2022Mar 31, 2022-2226.2%–

More Lipella Pharmaceuticals figures

See a number that looks wrong?